• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1反应中心环中用于识别纤溶酶原激活物的序列要求。

Sequence requirements in the reactive-center loop of plasminogen-activator inhibitor-1 for recognition of plasminogen activators.

作者信息

Tucker H M, Gerard R D

机构信息

Department of Biochemistry, University of Texas, Southwestern Medical Center, Dallas, USA.

出版信息

Eur J Biochem. 1996 Apr 1;237(1):180-7. doi: 10.1111/j.1432-1033.1996.0180n.x.

DOI:10.1111/j.1432-1033.1996.0180n.x
PMID:8620872
Abstract

Plasminogen activator inhibitor-1 (PAI-1) is a member of the serpin superfamily of proteins and is the fast acting inhibitor of both urinary plasminogen activator and tissue-type plasminogen activator. We have assessed the functional significance of reactive center residues on the carboxy-terminal side of the cleavage site of recombinant human PAI-1. Using site-directed mutagenesis, the P1'-P5' residues (P1' is the first residue on the carboxy-terminal side of the protease cleavage site) of the wild-type PAI-1 reactive center sequence were replaced with the corresponding sequences of plasminogen activator inhibitor-2, antithrombin, alpha 2-antiplasmin and protease nexin I. Rate constants of inhibition of the serine proteases urinary plasminogen activator, tissue-type plasminogen activator, plasmin and thrombin by the variants were determined. The results suggest a crucial role for both reactive center length and sequence in the inhibition of plasminogen activators by PAI-1. Analysis of substitutions at positions P4' and P5' both confirms and extends our previous work demonstrating a favorable electrostatic interaction between these residues and tissue-type plasminogen activator. None of the variants show dramatic increases in the rate constants of inhibition of other serine proteases, suggesting that these residues alone are not sufficient to confer protease specificity on PAI-1. Apparently, the determinants of the rapid inhibitory specificity of PAI-1 are localized to the P1'-P5' region of the reactive center and these residues act synergistically to produce the exquisite specificity of PAI-1 for plasminogen activators.

摘要

纤溶酶原激活物抑制剂-1(PAI-1)是丝氨酸蛋白酶抑制剂超家族的成员,是尿纤溶酶原激活物和组织型纤溶酶原激活物的快速作用抑制剂。我们评估了重组人PAI-1裂解位点羧基末端侧反应中心残基的功能意义。使用定点诱变,将野生型PAI-1反应中心序列的P1'-P5'残基(P1'是蛋白酶裂解位点羧基末端侧的第一个残基)替换为纤溶酶原激活物抑制剂-2、抗凝血酶、α2-抗纤溶酶和蛋白酶连接蛋白I的相应序列。测定了变体对丝氨酸蛋白酶尿纤溶酶原激活物、组织型纤溶酶原激活物、纤溶酶和凝血酶的抑制速率常数。结果表明反应中心长度和序列在PAI-1对纤溶酶原激活物的抑制中起关键作用。对P4'和P5'位置取代的分析证实并扩展了我们之前的工作,证明这些残基与组织型纤溶酶原激活物之间存在有利的静电相互作用。没有一个变体在其他丝氨酸蛋白酶的抑制速率常数上显示出显著增加,这表明仅这些残基不足以赋予PAI-1蛋白酶特异性。显然,PAI-1快速抑制特异性的决定因素定位于反应中心的P1'-P5'区域,这些残基协同作用以产生PAI-1对纤溶酶原激活物的精确特异性。

相似文献

1
Sequence requirements in the reactive-center loop of plasminogen-activator inhibitor-1 for recognition of plasminogen activators.纤溶酶原激活物抑制剂-1反应中心环中用于识别纤溶酶原激活物的序列要求。
Eur J Biochem. 1996 Apr 1;237(1):180-7. doi: 10.1111/j.1432-1033.1996.0180n.x.
2
Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.凝血酶与纤溶酶原激活物抑制剂-1反应缓慢的结构基础解析。
Biochemistry. 1998 Sep 22;37(38):13138-42. doi: 10.1021/bi9808518.
3
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center.纤溶酶原激活物抑制剂-1反应中心的饱和诱变
J Biol Chem. 1992 Apr 15;267(11):7588-95.
4
Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.对纤溶酶原激活物抑制剂1突变体的大型噬菌体展示文库进行选择性筛选,以定位与凝血酶或组织型纤溶酶原激活物可变区1的相互作用位点。
J Biol Chem. 1996 Mar 29;271(13):7423-8. doi: 10.1074/jbc.271.13.7423.
5
Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.纤溶酶原激活物抑制剂-1的底物行为与反应位点环插入缺失无关。
Biochemistry. 1996 Jun 11;35(23):7474-81. doi: 10.1021/bi960079d.
6
Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity.组织型纤溶酶原激活物特异性纤溶酶原激活物抑制剂-1突变体的鉴定。相互作用的第二位点有助于靶标特异性的证据。
J Biol Chem. 1995 Apr 21;270(16):9301-6. doi: 10.1074/jbc.270.16.9301.
7
Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition.丝氨酸蛋白酶抑制剂反应中心环的流动性是抑制剂功能所必需的,但不是酶识别所必需的。
J Biol Chem. 1994 Nov 4;269(44):27657-62.
8
Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1. The distance between P3 and P1' determined by donor-donor fluorescence energy transfer.活性中心裂解的1型纤溶酶原激活物抑制剂的生化与生物物理研究。通过供体-供体荧光能量转移测定P3与P1'之间的距离。
J Biol Chem. 1996 Aug 30;271(35):21231-8. doi: 10.1074/jbc.271.35.21231.
9
Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.蛋白质辅因子对丝氨酸蛋白酶抑制剂特异性的改变。纤连蛋白赋予纤溶酶原激活物抑制剂1凝血酶抑制特性。
J Biol Chem. 1990 Aug 5;265(22):13029-35.
10
Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop.通过活性位点环中的点突变将纤溶酶原激活物抑制剂-1从抑制剂转化为底物。
J Biol Chem. 1994 Jul 29;269(30):19559-64.

引用本文的文献

1
Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.基质金属蛋白酶-9通过裂解蛋白酶神经素-1来调节肿瘤细胞的侵袭。
Cancer Res. 2010 Sep 1;70(17):6988-98. doi: 10.1158/0008-5472.CAN-10-0242. Epub 2010 Aug 24.
2
Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule.纤溶酶原激活物抑制剂1分子中苯丙氨酸113至天冬氨酸138区域单个氨基酸取代的功能效应。
Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):409-15. doi: 10.1042/bj3310409.